Embecta (EMBC) Competitors

Embecta (NASDAQ:EMBC) and National Vision (NASDAQ:EYE) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Does the media favor EMBC or EYE?

In the previous week, National Vision had 11 more articles in the media than Embecta. MarketBeat recorded 13 mentions for National Vision and 2 mentions for Embecta. National Vision's average media sentiment score of 1.20 beat Embecta's score of 1.13 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	5 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate EMBC or EYE?

Embecta presently has a consensus price target of $19.00, indicating a potential upside of 90.76%. National Vision has a consensus price target of $24.18, indicating a potential downside of 0.12%. Given Embecta's higher probable upside, research analysts plainly believe Embecta is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
National Vision	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Is EMBC or EYE more profitable?

Embecta has a net margin of 4.89% compared to National Vision's net margin of -1.40%. National Vision's return on equity of 3.44% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	4.89%	-19.67%	12.27%
National Vision	-1.40%	3.44%	1.40%

Which has more risk and volatility, EMBC or EYE?

Embecta has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Which has stronger earnings & valuation, EMBC or EYE?

Embecta has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08B	0.54	$78.30M	$0.90	11.07
National Vision	$1.82B	1.05	-$28.50M	-$0.33	-73.36

Do insiders & institutionals believe in EMBC or EYE?

93.8% of Embecta shares are owned by institutional investors. 0.4% of Embecta shares are owned by company insiders. Comparatively, 2.7% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

National Vision beats Embecta on 9 of the 16 factors compared between the two stocks.